Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Hansmann

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
Leukemia|March 22, 2007
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphomaC Renné, K Willenbrock, J I Martin-Subero, et al.
Leukemia & Lymphoma|October 8, 1999
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomasM J Rummel, K U Chow, E Jäger, et al.
International Journal of Cancer|May 16, 1996
Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID miceR Schnell, A A Katouzi, C Linnartz, et al.
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's DiseaseV Diehl, M Sextro, J Franklin, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 12, 2009
[Retrospective 5-year analysis of MR-guided biopsies in a low-field MR system]S Zangos, C Müller, F Mayer, et al.
Gut|January 21, 2006
Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritisM Hummel, S Oeschger, T F E Barth, et al.
Leukemia|February 7, 2012
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infectionJ Peveling-Oberhag, G Crisman, A Schmidt, et al.
Histopathology|April 22, 2005
Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Blood|January 15, 1997
A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphomaA Engert, V Diehl, R Schnell, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Leukemia|March 22, 2007
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphomaC Renné, K Willenbrock, J I Martin-Subero, et al.
Leukemia & Lymphoma|October 8, 1999
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomasM J Rummel, K U Chow, E Jäger, et al.
International Journal of Cancer|May 16, 1996
Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID miceR Schnell, A A Katouzi, C Linnartz, et al.
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's DiseaseV Diehl, M Sextro, J Franklin, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 12, 2009
[Retrospective 5-year analysis of MR-guided biopsies in a low-field MR system]S Zangos, C Müller, F Mayer, et al.
Gut|January 21, 2006
Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritisM Hummel, S Oeschger, T F E Barth, et al.
Leukemia|February 7, 2012
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infectionJ Peveling-Oberhag, G Crisman, A Schmidt, et al.
Histopathology|April 22, 2005
Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Blood|January 15, 1997
A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphomaA Engert, V Diehl, R Schnell, et al.
Pageof 24